Stock listing

A2P5PP Stock Price, News, Filings & Events — Larimar Therapeutics, Inc.

Selected listing: A2P5PP · LSX · EUR · DE

A2P5PP:LSX represents Larimar Therapeutics, Inc., a biopharmaceutical company focused on developing treatments for rare diseases. The company is advancing its lead product candidate, which targets a specific genetic condition, and has recently made progress in its clinical trials. Investors can find the latest news, regulatory filings, and upcoming events related to Larimar Therapeutics on this page, providing insights into its market activities and developments. The context of the biopharmaceutical sector continues to evolve, impacting Larimar's strategic direction and potential growth.